APA (7th ed.) Citation

H, v. L., R, V., M, v. B. H., NH, M., R, v. H., M, S., . . . PSN, v. R. (2025). Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: A nationwide cohort study in the Netherlands. EClinicalMedicine, 80, 103067. https://doi.org/10.1016/j.eclinm.2024.103067

Chicago Style (17th ed.) Citation

H, van Laarhoven, et al. "Real-world Outcomes of the CROSS Regimen in Patients with Resectable Esophageal or Gastro-esophageal Junction Adenocarcinoma: A Nationwide Cohort Study in the Netherlands." EClinicalMedicine 80 (2025): 103067. https://doi.org/10.1016/j.eclinm.2024.103067.

MLA (9th ed.) Citation

H, van Laarhoven, et al. "Real-world Outcomes of the CROSS Regimen in Patients with Resectable Esophageal or Gastro-esophageal Junction Adenocarcinoma: A Nationwide Cohort Study in the Netherlands." EClinicalMedicine, vol. 80, 2025, p. 103067, https://doi.org/10.1016/j.eclinm.2024.103067.